3160 PORTER DR., PALO ALTO, CA
Market cap: $14.5B (12/18/2025)
Price: $76.30
Reports Positive Phase 3 Topline Results for Encaleret in Patients with Autosomal Dominant Hypocalcemia Type 1
Reports Third Quarter 2025 Financial Results and Business Updates
BridgeBio's Positive Phase 3 Results for BBP-418 in LGMD2I/R9
Reports Second Quarter 2025 Financial Results and Business Updates
Material disclosure
News, Articles of Incorporation, Material Contracts
Annual Report to Security Holders
Reports First Quarter 2025 Financial Results and Business Updates
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Confidential Treatment Order